NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP
Avita Medical, Inc. RCEL
8 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$71.6M
▲ 12.1% vs FY2024
EPS · FY25
$-1.74
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
—
Net margin · FY25
-67.8%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 71.6M
Revenue, FY2025 · full 8-year series below
Revenue
Net income
The company lost 68 cents on every revenue dollar this year.
Per share
USD -1.74
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
—
Return on equity, FY2025
ROE
Operating margin-59.4%
Net margin-67.8%
Return on assets-71.4%
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+19.6% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+27.7%
+19.6%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.03B
Shares outstanding, FY2025
Change, 5 years+22.8%
Change, 10 years—
The share count grew 23% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 56.4M
total assets, end of FY2025
Total assetsUSD 56.4M
EquityUSD -16.6M
CashUSD 10.2M
Gross debtUSD 43.0M
Net debtUSD 32.7M
Current ratio0.57×
Net debt stands at -197% of equity.
History
8 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2020
2019
2018
2017
Revenue $B
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.0
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.0
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
Net income $B
−0.0
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−1.74
−2.39
−1.40
−1.07
−1.17
−2.07
−1.56
−1.37
Dividend / sh $
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
ROE %
·
−231.0
−52.9
−28.2
−28.3
−90.2
−144.0
−141.8
Shares out B
0.03
0.03
0.03
0.03
0.02
0.02
0.02
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
32 of 32
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed